--- topic: "Migraines" title: "Natural Prevention Strategies" order: 1 description: "Evidence-based natural approaches to reducing migraine frequency and severity, including magnesium, riboflavin, CoQ10, and dietary triggers" question: "Do magnesium, CoQ10 and riboflavin help prevent migraines?" answer: "Magnesium, CoQ10 and riboflavin likely cut migraine frequency modestly; magnesium has the most support, but the trials are small." actions: - "Keep a regular sleep schedule, even on weekends, and a 4–6 week trigger diary to find personal triggers." - "Consider magnesium glycinate, malate or citrate (not oxide), typically 400–600 mg daily with food; the 12-week trial used 600 mg [1]." - "CoQ10 (300 mg daily, as 100 mg three times) beat placebo in a 42-person trial; allow about 3 months to judge [2]." cautions: - "Butterbur can contain liver-toxic pyrrolizidine alkaloids, and the American Academy of Neurology withdrew its recommendation in 2015 after liver injury reports." - "Feverfew works only as a daily preventive, not an acute treatment, and preparations vary in strength, so results are inconsistent [4]." - "Magnesium trials showed the clearest benefit in deficient patients; benefit in non-deficient patients is less certain [5]." confidence: 3 confidenceNote: "Placebo-controlled RCTs of 81 (magnesium), 42 (CoQ10) and 130 (combination) people were positive but small; the combination trial missed significance for migraine days." evidenceSummary: rctCount: 3 observationalCount: 0 metaAnalysisCount: 2 totalParticipants: "~600" replicated: true newestStudyYear: 2017 references: - id: "1" pmid: "8792038" title: "Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study" authors: "Peikert A, Wilimzig C, Köhne-Volland R" year: 1996 journal: "Cephalalgia" - id: "2" pmid: "15728298" title: "Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial" authors: "Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J" year: 2005 journal: "Neurology" - id: "3" pmid: "25916335" title: "Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial" authors: "Gaul C, Diener HC, Danesch U, Migravent Study Group" year: 2015 journal: "The Journal of Headache and Pain" - id: "4" pmid: "9950629" title: "Feverfew as a preventive treatment for migraine: a systematic review" authors: "Vogler BK, Pittler MH, Ernst E" year: 1998 journal: "Cephalalgia" - id: "5" pmid: "29131326" title: "Magnesium in Migraine Prophylaxis — Is There an Evidence-Based Rationale? A Systematic Review" authors: "von Luckner A, Riederer F" year: 2017 journal: "Headache: The Journal of Head and Face Pain" --- Migraines affect roughly 1 billion people worldwide and are among the most disabling neurological conditions. Rather than being purely a headache disorder, migraines involve changes in brain chemistry, blood vessel behavior, and neurotransmitter signaling. Several well-studied natural interventions — particularly magnesium, riboflavin (vitamin B2), and CoQ10 — have clinical evidence supporting their use as preventive strategies, with effects comparable to some pharmaceutical prophylactics. [1][2][3] ## Why Migraines Happen Migraines are not simply "bad headaches." They involve a wave of electrical and chemical changes across the brain called cortical spreading depression, followed by inflammation of pain-sensitive blood vessels surrounding the brain. Several nutritional deficiencies are consistently found in migraineurs: - **Magnesium deficiency** is found in up to 50% of people during acute migraine attacks. Magnesium plays a central role in regulating glutamate receptors and suppressing cortical spreading depression. [1] - **Mitochondrial dysfunction** appears to drive migraine susceptibility in many patients — the brain during a migraine shows signs of impaired energy metabolism, which is why CoQ10 and riboflavin (both critical to mitochondrial function) reduce attack frequency. [2] - **Serotonin dysregulation** connects migraines to gut health, sleep, and stress, explaining why these factors commonly trigger attacks. ## Magnesium: The Most Evidence-Backed Supplement Oral magnesium supplementation has the strongest evidence base of any natural migraine preventive. In a double-blind, placebo-controlled multicenter trial of 81 patients, 600 mg/day of magnesium trimagnesium dicitrate for 12 weeks reduced attack frequency by 41.6% versus only 15.8% in the placebo group during weeks 9–12. [1] The most bioavailable forms for migraine prevention are **magnesium glycinate**, **magnesium malate**, and **magnesium citrate** — magnesium oxide is poorly absorbed and less useful. A typical preventive dose is 400–600 mg daily, taken with food to reduce digestive upset. The American Headache Society and the American Academy of Neurology give magnesium a Grade B recommendation for migraine prevention, making it one of the few supplements with official clinical endorsement. ## CoQ10: Mitochondrial Support Coenzyme Q10 at 300 mg/day (100 mg three times daily) was superior to placebo in a randomized controlled trial of 42 migraine patients, achieving a 50% responder rate of 47.6% versus 14.4% for placebo after 3 months. Headache days, attack frequency, and days with nausea all improved significantly. [2] CoQ10 works by supporting the electron transport chain in mitochondria, correcting the energy deficit that makes the migraine brain vulnerable to triggers. Ubiquinol (the reduced form) may be better absorbed than ubiquinone, particularly for people over 40. ## Riboflavin (Vitamin B2): Simple and Effective Riboflavin at 400 mg/day is one of the best-tolerated migraine preventives and supports mitochondrial energy production through its role in the respiratory chain. A multicenter randomized trial combining riboflavin (400 mg), magnesium (600 mg), and CoQ10 (150 mg) found significant reductions in migraine pain intensity and migraine-related disability (measured by HIT-6 scores) compared to placebo over 3 months. [3] High-dose riboflavin turns urine bright yellow — this is harmless and actually serves as a compliance indicator. ## Feverfew: Traditional Herbal Prevention Feverfew (*Tanacetum parthenium*) has been used to prevent migraines for centuries. A systematic review of five randomized, placebo-controlled trials found that most favored feverfew over placebo, although its authors said the effectiveness of feverfew for preventing migraine has not been established beyond reasonable doubt. [4] The active compound parthenolide inhibits platelet aggregation and reduces prostaglandin release, both of which contribute to migraine pain. Typical dose is 50–100 mg of dried leaf extract daily. Note: feverfew should be taken continuously rather than acutely — it is a preventive, not an abortive treatment. ## Dietary Triggers and Identification Common dietary migraine triggers include: - **Tyramine** — found in aged cheeses, fermented foods, and red wine - **Histamine** — found in alcohol, cured meats, and fermented foods (see our [histamine intolerance page](/histamine-intolerance/symptoms-and-management) for more) - **Caffeine withdrawal** — sudden reduction after habitual use - **Artificial sweeteners** — particularly aspartame - **MSG** — in processed foods and certain cuisines - **Skipping meals** — blood sugar drops are potent triggers A trigger diary for 4–6 weeks helps identify personal patterns, since triggers are highly individual. ## Lifestyle Factors Sleep regularity is one of the most powerful modifiable factors — both too little and too much sleep trigger migraines. Maintaining a consistent sleep-wake schedule, even on weekends, dramatically reduces attack frequency for many people. See our [sleep hygiene page](/sleep/sleep-hygiene) for practical guidance. Stress and hormonal fluctuations (particularly estrogen drops before menstruation) are common triggers. Regular aerobic exercise, practiced consistently rather than sporadically, has been shown to reduce attack frequency — but intense sudden exercise can paradoxically trigger attacks in susceptible individuals. ## Evidence Review ### Magnesium The Peikert et al. (1996) double-blind, multicenter trial remains the foundational magnesium evidence. In 81 patients with IHS-criteria migraines averaging 3.6 attacks/month, trimagnesium dicitrate 600 mg/day for 12 weeks produced a 41.6% reduction in attack frequency (weeks 9–12) compared to 15.8% in the placebo arm (p < 0.05). The number of days with migraine and symptomatic medication consumption also declined significantly in the treatment group. [1] A 2017 systematic review assessed multiple magnesium trials and concluded that while the evidence supports magnesium as a preventive, the studies are heterogeneous in form, dose, and patient selection. Oral magnesium in deficient patients consistently outperforms placebo; benefit in non-deficient patients is less certain. The reviewers noted a strong safety profile and low cost make it a reasonable first-line option. [5] The mechanism is well-characterized: magnesium blocks NMDA glutamate receptors, inhibits cortical spreading depression, modulates serotonin release, and reduces platelet aggregation — all pathways implicated in migraine initiation and propagation. ### CoQ10 Sándor et al. (2005, Neurology) conducted a rigorous double-blind, randomized, placebo-controlled crossover trial in 42 patients. CoQ10 at 3 × 100 mg/day reduced attack frequency from a mean of 4.4 to 3.2 attacks/month by the third treatment month (p < 0.001). The 50% responder rate was 47.6% for CoQ10 versus 14.4% for placebo. Headache days and nausea days showed similar improvement. Tolerability was excellent with no significant adverse events. [2] The proposed mechanism centers on mitochondrial dysfunction in migraine: measurements of mitochondrial oxygen consumption in migraine patients show impaired phosphorylation efficiency. CoQ10 acts as an electron carrier in the mitochondrial respiratory chain and has antioxidant properties that may reduce neuroinflammation. ### Combined Nutraceuticals Gaul et al. (2015, Journal of Headache and Pain) conducted the first multicenter RCT testing a combined formulation of riboflavin (400 mg), magnesium (600 mg), and CoQ10 (150 mg) in 130 adults with ≥3 migraines/month. The 3-month treatment period produced a statistically significant reduction in maximum migraine pain intensity and a significant improvement in the HIT-6 migraine disability score. Absolute migraine day frequency trended toward reduction but did not reach significance, likely due to underpowering. [3] This combination approach is rational given that each agent targets overlapping but distinct aspects of mitochondrial dysfunction and neuroinflammation. ### Feverfew Vogler, Pittler, and Ernst (1998, Cephalalgia) published a systematic review that included only randomized, placebo-controlled, double-blind trials; five trials met the criteria and the majority favored feverfew over placebo. The reviewers stressed important caveats and concluded that the clinical effectiveness of feverfew in the prevention of migraine has not been established beyond reasonable doubt. [4] Limitations include heterogeneous preparations — dried leaf extracts with variable parthenolide content have produced inconsistent results. Standardized extracts (0.2–0.4% parthenolide content) show more consistent benefit than whole-herb preparations. ### Butterbur: A Note on Safety Butterbur (*Petasites hybridus*) root extract at 75 mg twice daily reduced migraine attack frequency by 48% in a well-designed RCT. However, raw butterbur contains pyrrolizidine alkaloids (PAs) which are hepatotoxic and potentially carcinogenic. The American Academy of Neurology removed its recommendation for butterbur in 2015 following reports of liver injury. Only PA-free certified extracts (e.g., Petadolex) were used in clinical trials, but ongoing safety uncertainty makes feverfew and the nutrient interventions preferable options. ### Strength of Evidence - **Magnesium 400–600 mg/day:** Grade B evidence (AAN/AHS); most trials positive; low cost, excellent safety - **Riboflavin 400 mg/day:** Grade B evidence; well-tolerated; especially effective in patients with mitochondrial variants - **CoQ10 300 mg/day:** Grade C/B evidence; one strong RCT; notable responder rate in trials - **Feverfew 50–100 mg/day:** Grade B evidence for standardized extracts; variable across preparations - **Dietary trigger identification:** Grade C; highly individualized; diary-based identification is standard clinical practice